JP2019520083A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019520083A5 JP2019520083A5 JP2019500781A JP2019500781A JP2019520083A5 JP 2019520083 A5 JP2019520083 A5 JP 2019520083A5 JP 2019500781 A JP2019500781 A JP 2019500781A JP 2019500781 A JP2019500781 A JP 2019500781A JP 2019520083 A5 JP2019520083 A5 JP 2019520083A5
- Authority
- JP
- Japan
- Prior art keywords
- substitution
- seq
- position corresponding
- polypeptide
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023029563A JP2023060001A (ja) | 2016-07-11 | 2023-02-28 | セレノシステインを含む組換えポリペプチド及びその製造方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662360745P | 2016-07-11 | 2016-07-11 | |
| US62/360,745 | 2016-07-11 | ||
| PCT/US2017/041373 WO2018013481A1 (en) | 2016-07-11 | 2017-07-10 | Recombinant polypeptides comprising selenocysteine and method for producing the same |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023029563A Division JP2023060001A (ja) | 2016-07-11 | 2023-02-28 | セレノシステインを含む組換えポリペプチド及びその製造方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019520083A JP2019520083A (ja) | 2019-07-18 |
| JP2019520083A5 true JP2019520083A5 (enExample) | 2020-08-20 |
| JP7269648B2 JP7269648B2 (ja) | 2023-05-09 |
Family
ID=60953318
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019500781A Active JP7269648B2 (ja) | 2016-07-11 | 2017-07-10 | セレノシステインを含む組換えポリペプチド及びその製造方法 |
| JP2023029563A Withdrawn JP2023060001A (ja) | 2016-07-11 | 2023-02-28 | セレノシステインを含む組換えポリペプチド及びその製造方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023029563A Withdrawn JP2023060001A (ja) | 2016-07-11 | 2023-02-28 | セレノシステインを含む組換えポリペプチド及びその製造方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11155804B2 (enExample) |
| EP (1) | EP3481945A4 (enExample) |
| JP (2) | JP7269648B2 (enExample) |
| CN (1) | CN109844105A (enExample) |
| CA (1) | CA3030163A1 (enExample) |
| WO (1) | WO2018013481A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3506945A4 (en) * | 2016-08-30 | 2020-07-15 | Board of Regents, The University of Texas System | PRODUCTION OF SELENO-BIOLOGICALS IN GENETICALLY RECODED ORGANISMS |
| CN109486802B (zh) * | 2018-12-26 | 2020-08-04 | 广州白云山拜迪生物医药有限公司 | 一种酶活提高的青霉素酶突变体及其构建方法 |
| WO2025024577A1 (en) * | 2023-07-24 | 2025-01-30 | Board Of Regents, The University Of Texas System | Incorporating unnatural amino acids using one pot pure system |
| CN120158472A (zh) * | 2023-10-18 | 2025-06-17 | 河南农业大学 | 玉米ZmmtRF2a基因及其克隆引物在调控籽粒发育中的应用 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10309193A (ja) * | 1997-05-12 | 1998-11-24 | Sankyo Co Ltd | 哺乳類セレノシステイン含有タンパク質の大腸菌での製造法 |
| US6849417B1 (en) | 1998-04-06 | 2005-02-01 | The United States Of America As Represented By The Department Of Health And Human Services | Mammalian selenoprotein differentially expressed in tumor cells |
| AU6987200A (en) * | 1999-08-16 | 2001-03-13 | Karolinska Innovations Ab | Methods and means for selenoprotein expression |
| JP4199662B2 (ja) * | 2001-09-13 | 2008-12-17 | 財団法人化学及血清療法研究所 | 新規なセレノシステイン含有タンパク質 |
| WO2007075438A2 (en) | 2005-12-15 | 2007-07-05 | Codon Devices, Inc. | Polypeptides comprising unnatural amino acids, methods for their production and uses therefor |
| NZ576445A (en) * | 2006-11-02 | 2012-03-30 | Daniel J Capon | Hybrid immunoglobulins with moving parts |
| US20090155255A1 (en) | 2007-09-27 | 2009-06-18 | Biogen Idec Ma Inc. | Cd23 binding molecules and methods of use thereof |
| US8946148B2 (en) | 2007-11-20 | 2015-02-03 | Ambrx, Inc. | Modified insulin polypeptides and their uses |
| ES2746559T3 (es) | 2011-01-28 | 2020-03-06 | Nat Res Council Canada | Modificación genética de dominios de inmunoglobulina |
| ES2724778T3 (es) | 2011-06-10 | 2019-09-16 | Bioverativ Therapeutics Inc | Compuestos procoagulantes y procedimientos de uso de los mismos |
| WO2013009868A1 (en) | 2011-07-11 | 2013-01-17 | Yale University | Compositions and methods for making selenocysteine containing polypeptides |
| US10240158B2 (en) | 2011-07-11 | 2019-03-26 | Yale University | Compositions and methods for making selenocysteine containing polypeptides |
| US10876142B2 (en) | 2011-07-11 | 2020-12-29 | Yale University | Compositions and methods for making selenocysteine containing polypeptides |
| US10351626B2 (en) | 2013-03-14 | 2019-07-16 | The Scripps Research Institute | Targeting agent antibody conjugates and uses thereof |
| US20150050682A1 (en) * | 2013-08-15 | 2015-02-19 | University Of Vermont And State Agricultural College | Direct assay of thioredoxin reductase activity |
| WO2015066543A1 (en) | 2013-11-01 | 2015-05-07 | Board Of Regents, The University Of Texas System | Targeting her2 and her3 with bispecific antibodies in cancerous cells |
| US10118950B2 (en) * | 2014-08-30 | 2018-11-06 | Northwestern University | Platforms for cell-free protein synthesis comprising extracts from genomically recoded E. coli strains having genetic knock-out mutations in release factor 1 (RF-1) and endA |
| WO2016172269A2 (en) | 2015-04-20 | 2016-10-27 | University Of Utah Research Foundation | Insulin analogs having shortened b chain peptides and associated methods |
| US10557160B2 (en) * | 2015-12-15 | 2020-02-11 | Board Of Regents, The University Of Texas System | Transgenic bacteria with expanded amino acid usage and nucleic acid molecules for use in the same |
| CA3030930A1 (en) | 2016-07-22 | 2018-01-25 | University Of Utah Research Foundation | Insulin analogs |
| EP3506945A4 (en) | 2016-08-30 | 2020-07-15 | Board of Regents, The University of Texas System | PRODUCTION OF SELENO-BIOLOGICALS IN GENETICALLY RECODED ORGANISMS |
-
2017
- 2017-07-10 EP EP17828247.1A patent/EP3481945A4/en active Pending
- 2017-07-10 WO PCT/US2017/041373 patent/WO2018013481A1/en not_active Ceased
- 2017-07-10 CA CA3030163A patent/CA3030163A1/en active Pending
- 2017-07-10 CN CN201780048121.5A patent/CN109844105A/zh active Pending
- 2017-07-10 US US16/316,768 patent/US11155804B2/en active Active
- 2017-07-10 JP JP2019500781A patent/JP7269648B2/ja active Active
-
2023
- 2023-02-28 JP JP2023029563A patent/JP2023060001A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Amiche et al. | The dermaseptin precursors: a protein family with a common preproregion and a variable C-terminal antimicrobial domain | |
| Derewenda et al. | The structure of Yersinia pestis V-antigen, an essential virulence factor and mediator of immunity against plague | |
| JP2007530435A5 (enExample) | ||
| JP2017506075A5 (enExample) | ||
| Sun et al. | A novel cathelicidin from Bufo bufo gargarizans Cantor showed specific activity to its habitat bacteria | |
| JP2019520083A5 (enExample) | ||
| WO2018028635A1 (zh) | 一种寨卡病毒人源单克隆抗体及其应用 | |
| KR20160010466A (ko) | Ｉｃｏｓｌ에 대한 치료학적 표적 특이적 ｖｎａｒ 도메인의 단리 | |
| RU2016135788A (ru) | Иммуноконъюгаты интерлейкина 10 | |
| JP5750373B2 (ja) | 慢性炎症性応答の調節および自己免疫疾患の処置のためのｉｌ−４由来ペプチド | |
| JP2009511000A5 (enExample) | ||
| CA3195315A1 (en) | Compositions and methods for selective depletion of target molecules | |
| CN106636050A (zh) | 来源于耐甲氧西林金黄色葡萄球菌噬菌体的宽谱内溶素及其应用 | |
| CN106380517B (zh) | 一种对中东呼吸综合征冠状病毒具有中和活性的小分子抗体及其应用 | |
| CN101307100B (zh) | 一种抗菌肽的多肽片段及其核苷酸序列和应用 | |
| KR101774354B1 (ko) | Z-도메인 및 칼시퀘스트린 융합 단백질을 이용한 항체의 분리 및 정제 방법 | |
| Charbonnier et al. | Overexpression, refolding, and purification of the histidine-tagged outer membrane efflux protein OprM of Pseudomonas aeruginosa | |
| Wang et al. | Production and characterization of a novel antimicrobial peptide HKABF by Pichia pastoris | |
| Pyo et al. | Expression and purification of a recombinant buforin derivative from Escherichia coli | |
| KR102497267B1 (ko) | 반응성 및 안정성 그리고 항체회수가 향상된 z-도메인 및 칼시퀘스트린 융합단백질 및 이를 이용한 항체의 분리 및 정제 방법 | |
| JP5757555B2 (ja) | 新規酸性プロテアーゼ及びその用途 | |
| Patel | Predicted secondary structure of the N-terminal sequence of the lac repressor and proposed models for its complexation to the lac operator | |
| CN120025428B (zh) | 一种靶向NS3a的纳米抗体及其应用 | |
| Halami et al. | Heterologous expression, purification and refolding of an anti-listerial peptide produced by Pediococcus acidilactici K7 | |
| CN114605555B (zh) | 一种抗新型冠状病毒SARS-CoV-2的双特异中和抗体及其应用 |